Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6249 of 6351
-
Lung transplant machine study ends early with just one patient
Knowledge-focused Stopped earlyClinical use of ex-vivo perfusion for lung transplantation. Collection, storage and processing of patient data for outcome analysis.
Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Healthy volunteers test two versions of experimental drug
Knowledge-focused CompletedARN-75039-103 is a comparative, randomized, single-dose, cross-over study to assess the PK, safety, and tolerability of neat ARN-75039 in hydroxypropyl methylcellulose (HPMC) capsules compared with ARN-75039 with excipients in tablet form, both administered orally, in healthy adu…
Phase 1 • Sponsor: Arisan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Healthy volunteers help check new Drug's safety
Knowledge-focused CompletedThe purpose of this study is to investigate the safety, tolerability, and pharmacokinetics of BMS-986419 (Part 1) and the effects of multiple doses of BMS-986419 on cardiac repolarization (Part 2) in healthy participants.
Phase 1 • Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New malaria pill takes first step: is it safe for humans?
Knowledge-focused OngoingThe primary purpose of the study is to evaluate the safety and tolerability of single ascending oral doses of E1018 in healthy adult participants and to evaluate the pharmacokinetics (PK) of E1018 in plasma and urine after single oral dose administration.
Phase 1 • Sponsor: Eisai Inc. • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Scientists track mystery Drug's journey through healthy volunteers
Knowledge-focused CompletedTo evaluate the absorption, metabolism and excretion in healthy Chinese male subjects after a single oral dose of \[14C\]HMPL-453
Phase 1 • Sponsor: Hutchmed • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Healthy volunteers help test new Drug's absorption
Knowledge-focused CompletedThis study will assess the relative bioavailability and effect of food on pharmacokinetics of ABBV-932 oral administration in healthy adult participants.
Phase 1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Healthy men swallow radioactive drug to track its journey through the body
Knowledge-focused CompletedThis clinical study is designed to study the mass balance of a single dose of varegacestat in healthy male participants.
Phase 1 • Sponsor: Immunome, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Healthy volunteers help test new drug for brain inflammation
Knowledge-focused CompletedThis study will evaluate the safety, tolerability, and pharmacokinetics (PK) of ART5803 following IVIG administration in healthy participants to investigate the potential interactions between ART5803 and IVIG
Phase 1 • Sponsor: Arialys Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New drug ENERGI-F705 takes first step: safety check in 24 volunteers
Knowledge-focused CompletedTo evaluate the safety, the tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) of ENERGI-F705 Tablets in healthy subjects.
Phase 1 • Sponsor: Energenesis Biomedical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Heart safety check for experimental drug varegacestat
Knowledge-focused CompletedThis clinical study is designed to study the effect of a single dose of varegacestat on cardiac repolarization in healthy adult participants.
Phase 1 • Sponsor: Immunome, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New drug ENX-104 tested in healthy volunteers for safety and brain activity
Knowledge-focused CompletedThe study is designed to evaluate the D2/D3 receptor occupancy (RO), safety, tolerability, and pharmacokinetics (PK) of ENX-104 in healthy volunteers.
Phase 1 • Sponsor: Engrail Therapeutics INC • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Can online peer coaching boost med Students' exam performance?
Knowledge-focused CompletedThis randomized educational trial compares two peer-support approaches for teaching clinical skills to medical students. Participants are randomly assigned to one of three groups: (1) Digital interactive peer support delivered through an online platform with structured tasks and …
Sponsor: Çanakkale Onsekiz Mart University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Singapore study asks seniors about their food choices
Knowledge-focused CompletedThis study is a cross-sectional study, aiming to recruit 200 community-dwelling elderly, aged 60 years and above. Recruitments will be made from St. Luke's ElderCare's (SLEC) active aging hubs around Singapore. The investigators will recruit approximately 70% Chinese, 20% Malay a…
Sponsor: Singapore Institute of Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
CBD safety check: new study tests supplement in 200 healthy adults
Knowledge-focused Recruiting nowThe present study is a randomized, placebo-controlled, parallel study. 250 participants will be screened, and considering a screening failure rate of 20%, approximately 200 participants will be randomized in a ratio of 1:1:1:1:1 to receive either different doses of VL-SE-01 or pl…
Sponsor: Vedic Lifesciences Pvt. Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Drug tracking study in healthy men completed
Knowledge-focused CompletedMass Balance Study of \[14C\] TJ0113 in Healthy Chinese Subjects
Phase 1 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Healthy volunteers test new drug MORF-440 for safety
Knowledge-focused CompletedThe purpose of this study is to evaluate the safety and tolerability of single ascending doses of MORF-440 administered to healthy participants single-ascending dose (SAD) and maximum ascending dose (MAD) substudy.
Phase 1 • Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New inhaled drug RCS-21 put to first safety test in humans
Knowledge-focused Recruiting nowThe goal of this clinical trial is to evaluate the safety and tolerability of RCS-21 in healthy volunteers. Participants will be asked to inhale a single dose of RCS-21 and their health status will be constantly monitored.
Phase 1 • Sponsor: RNATICS GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Flash of genius? light training may boost athlete reaction time
Knowledge-focused Stopped earlyThe purpose of this study is to assess the reliability of outcomes collected using a speed and cognitive light training system. This study will also be used to understand the effects of brain training on athletic performance using the FITLIGHT System.
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:59 UTC
-
Generic diabetes combo drug put to the test in healthy volunteers
Knowledge-focused CompletedProspective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study
Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Phone posture study: how your screen time strains your neck
Knowledge-focused CompletedThe aim of this study is to investigate the effect of smartphone use on head and neck flexion angle during sitting and standing positions.
Sponsor: Kutahya Health Sciences University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC